BB
Bespoke Biotherapeutics specializes in engineered B-cell therapeutics designed to target and eliminate specific cancer cells. This approach addresses the limitations of traditional therapies by providing a tailored treatment option that enhances patient outcomes and minimizes side effects.
Updated 20 months ago
Funding
$256K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NS
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Bespoke Biotherapeutics specializes in engineered B-cell therapeutics designed to target and eliminate specific cancer cells. This approach addresses the limitations of traditional therapies by providing a tailored treatment option that enhances patient outcomes and minimizes side effects.